Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs + WLL for Pneumoconiosis
NCT02668068Phase 1Completed
- Start
- Jan 2016
- Primary completion
- Mar 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of human umbilical cord mesenchymal stem cells in pneumoconiosis (2 arms). Primary endpoints: Incidence of Treatment-Emergent Adverse Events at 6 months and Quantitative analysis of CT density histograms at 6 months. Started Jan 2016; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
pneumoconiosis
Beyond the preview
Go deeper on NCT02668068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668068.